… since patients with vascular antiphospholipid syndrome (APS) and carriers of aPL were
considered together.16,–,18 The aim of the present study was to assess risk factors for a first …

Objectives The long-term prognosis of individuals fulfilling the laboratory criteria, but not
clinical criteria, of antiphospholipid syndrome (APS) has not been widely investigated. The …

… antiphospholipid antibodies (aPL), such as anticardiolipin antibodies (aCL), anti beta 2
glycoprotein antibodies (… incidence of antiphospholipid antibodies, especially antibodies not …

… anticoagulants and anticardiolipin antibodies and thrombosis has … by factors such as
differences in study design and eligibility criteria and by the diversity of antiphospholipid antibodies …

… antibodies are called antiphospholipid antibodies (APLAs; sometimes also abbreviated to
‘aPL’). In some people, these antibodies … elevated to be a clearer risk factor for blood clots and …

… comorbidities as statistically significant risk factors for vascular thrombosis or … risk factors.
The inconsistency with other studies showing smoking and oral contraceptive pill as risk factors …

… aCL IgG and aPS IgG antibodies are risk factors for stroke. … , their role as independent risk
factors in the pathogenesis of … factors (older age, malignancy and cardiovascular risk factors) […

… The antiphospholipid antibody results for the 99 patients in this study are summarized in …
aPL, comorbid diseases, and acquired risk factors for thrombosis. Thrombotic events included …

… and venous events were significant; in two studies IgG anti-β2GPI antibodies were also
independent risk factors for venous thrombosis. Moreover, the presence of a concomitant SLE …

… antiphospholipid antibodies was made in their paper, though one of their patients was
subsequently found to have anticardiolipin antibodies … antiphospholipid antibodies (antibodies to …